Mywy (Drospirenone, Ethinylestradiol | Lactose Anhydrous)

Drospirenone, the active ingredient in Mywy, is a combined oral contraceptive presented as an oral tablet for oral use. It is indicated for prevention of pregnancy and regulation of menstrual cycles in women of reproductive age.

GNH USA supplies Mywy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mywy is a combined hormonal contraceptive that acts on the reproductive endocrine system to prevent pregnancy and manage menstrual function. - Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns. - Management of dysmenorrhea: reduces menstrual pain associated with hormonal fluctuations.

Mywy may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea - Headache - Breast tenderness - Weight gain - Mood changes - Spotting or irregular bleeding

Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism) - Stroke - Myocardial infarction - Severe hypertension - Liver dysfunction or cholestasis - Allergic reactions such as anaphylaxis

Before prescribing Mywy, clinicians should evaluate patient history and risk factors. - Contraindicated in pregnancy: product is classified as Pregnancy Category X. - Avoid in women with a history of thromboembolic disorders: increased risk of clot formation. - Screen for hypertension: may exacerbate high blood pressure. - Assess for liver disease: impaired metabolism can alter drug levels. - Smoking in women over 35 years: significantly raises cardiovascular risk. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Mywy can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., rifampin, carbamazepine, phenytoin): may markedly reduce contraceptive effectiveness. - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase hormone plasma concentrations and risk of side effects.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline or metronidazole: may slightly lower contraceptive efficacy. - Anticonvulsants (phenobarbital, primidone): may decrease hormone levels. - Herbal supplements like St. John’s wort: may reduce effectiveness of the pill.